Stephanie Seymour graduated in 2017 from the University of Wisconsin-Madison with a Bachelor of Science in Molecular Biology and Economics with a math emphasis and Comprehensive Honors in the Liberal Arts. Stephanie spent 3.5 years conducting stem cell bioengineering research at the Wisconsin Institute for Discovery during her undergraduate education, co-authoring her first paper on the automated analysis of cell state at 19 years old. Later that year, she was selected as one of 20 students across the globe to be an Amgen Research Scholar and was sponsored to conduct cellular signaling research at the University of Tokyo’s Graduate School of Pharmaceutical Sciences, where she later presented her research to Amgen’s Vice President of Research and Development. She quickly developed an interest in the intersection between science, law and business, leading her to a Clinical Trial Operations internship at AbbVie Pharmaceuticals, and later founding UW-Madison’s first undergraduate science journal. After graduation, she accepted a summer role with CUNA Mutual Group as a Sales & Marketing Intern, supporting the Large Account Transformation Program, before starting Law School at the University of Wisconsin-Madison in the fall of 2017.
Throughout her undergraduate and law school career, Stephanie has pursued a variety of opportunities to enhance her scientific, legal and business knowledge. From lab work to legal work, she has sought out opportunities to work on the front lines of various industries in order to improve her inter-disciplinary communication. She is excited to pursue her MBA at the Wisconsin School of Business in the Erdman Center for Operations and Technology Management. She looks forward to developing the skills she will need to pursue a leadership career in healthcare and biotechnology in order to help patients more efficiently connect with the medicines, devices, and therapies they need.